Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials
- PMID: 28295905
- PMCID: PMC5523816
- DOI: 10.1111/obr.12528
Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials
Abstract
Objectives: Obesity is associated with significant morbidity and mortality rates. Even modest weight loss may be associated with health benefits. Alpha-lipoic acid (ALA) is a naturally occurring antioxidant. Studies have suggested anti-obesity properties of ALA; however, results are inconsistent. The purpose of this study is to conduct a meta-analysis of the effect of ALA on weight and body mass index (BMI).
Methods: A comprehensive, systematic literature search identified 10 articles on randomized, double-blind, placebo-controlled studies involving ALA. We conducted a meta-analysis of mean weight and BMI change differences between ALA and placebo treatment groups.
Results: Alpha-lipoic acid treatment coincided with a statistically significant 1.27 kg (confidence interval = 0.25 to 2.29) greater mean weight loss compared with the placebo group. A significant overall mean BMI difference of -0.43 kg/ m2 (confidence interval = -0.82 to -0.03) was found between the ALA and placebo groups. Meta-regression analysis showed no significance in ALA dose on BMI and weight changes. Study duration significantly affected BMI change, but not weight change.
Conclusions: Alpha-lipoic acid treatment showed small, yet significant short-term weight loss compared with placebo. Further research is needed to examine the effect of different doses and the long-term benefits of ALA on weight management.
Keywords: Alpha-lipoic acid; body mass; diabetes; thioctic acid.
© 2017 World Obesity Federation.
Conflict of interest statement
Potential conflicts of interest: Authors report no competing interests
Figures
Similar articles
-
Alpha-lipoic acid supplementation significantly reduces the risk of obesity in an updated systematic review and dose response meta-analysis of randomised placebo-controlled clinical trials.Int J Clin Pract. 2020 Jun;74(6):e13493. doi: 10.1111/ijcp.13493. Epub 2020 Mar 26. Int J Clin Pract. 2020. PMID: 32091656
-
Effects of oral α-lipoic acid administration on body weight in overweight or obese subjects: a crossover randomized, double-blind, placebo-controlled trial.Clin Endocrinol (Oxf). 2017 May;86(5):680-687. doi: 10.1111/cen.13303. Epub 2017 Feb 26. Clin Endocrinol (Oxf). 2017. PMID: 28239907 Clinical Trial.
-
Alpha-lipoic acid supplement in obesity treatment: A systematic review and meta-analysis of clinical trials.Clin Nutr. 2018 Apr;37(2):419-428. doi: 10.1016/j.clnu.2017.06.002. Epub 2017 Jun 8. Clin Nutr. 2018. PMID: 28629898
-
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.Diabetes. 1997 Sep;46 Suppl 2:S62-6. doi: 10.2337/diab.46.2.s62. Diabetes. 1997. PMID: 9285502 Review.
-
Alpha lipoic acid for dementia.Cochrane Database Syst Rev. 2004;(1):CD004244. doi: 10.1002/14651858.CD004244.pub2. Cochrane Database Syst Rev. 2004. PMID: 14974062 Review.
Cited by
-
Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment.Int J Mol Sci. 2024 Feb 25;25(5):2671. doi: 10.3390/ijms25052671. Int J Mol Sci. 2024. PMID: 38473918 Free PMC article. Review.
-
The effect of alpha-lipoic acid supplementation on anthropometric, glycemic, lipid, oxidative stress, and hormonal parameters in individuals with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.Obstet Gynecol Sci. 2024 Jan;67(1):17-29. doi: 10.5468/ogs.23206. Epub 2023 Dec 4. Obstet Gynecol Sci. 2024. PMID: 38044616 Free PMC article.
-
Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obes Pillars. 2022 Apr 6;2:100017. doi: 10.1016/j.obpill.2022.100017. eCollection 2022 Jun. Obes Pillars. 2022. PMID: 37990714 Free PMC article.
-
The effects of alpha lipoic acid (ALA) supplementation on blood pressure in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.Front Cardiovasc Med. 2023 Oct 24;10:1272837. doi: 10.3389/fcvm.2023.1272837. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37942070 Free PMC article. Review.
-
Nutritional supplements improve cardiovascular risk factors in overweight and obese patients: A Bayesian network meta-analysis.Front Nutr. 2023 Mar 30;10:1140019. doi: 10.3389/fnut.2023.1140019. eCollection 2023. Front Nutr. 2023. PMID: 37063314 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical